We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Technology Holistically Images Deep Living Tissue for The First Time

By LabMedica International staff writers
Posted on 16 Sep 2024

Tissue engineering involves the restoration or enhancement of cell and tissue function in the body by replacing defective counterparts with lab-grown ones. More...

This technique holds promise for a wide range of applications, such as cultivating cartilage to transplant into a patient's damaged knee. Since cartilage cannot regenerate itself, damage to it is a leading cause of osteoarthritis. The composition of transplanted cells and tissues is crucial for acceptance by the body. If the internal composition is compromised, there is a higher likelihood of rejection or poor function. This is particularly true for the extracellular matrix—the space between cells that determines cell structure and intercellular communication. Traditional imaging methods like fluorescence microscopy have used fluorescent labels to tag specific molecules within cells. However, these labels provide a limited view by gathering information only from tagged molecule groups and can be toxic, preventing the tissue from being suitable for transplantation.

In tissue engineering, this necessitates growing two sets of tissue cultures in the lab before transplantation into the body: one for examination to ensure the sample is safe and another for the actual transplant. This process is costly, and significant variability in the quality of lab-grown cell compositions means that even if scientists image a sample produced under the same conditions as the one intended for transplantation, they cannot be certain it will not be rejected. Now, a new device that uses light to non-destructively image tissue could revolutionize cartilage and tissue transplant treatments, laying the groundwork for osteoarthritis therapy.

Developed through collaborative research that included investigators from King's College London (London, UK), this new device is the first of its kind to reveal the molecular structure of deep tissue without relying on limiting fluorescent labels. Detailed in Nature Communications, this readily available machine could enhance the use of tissue engineering in medicine and halve the costs of tissue production in the lab. The researchers' approach, Raman Spectral Projection Tomography, builds on previous technologies that use light to provide a clear and non-invasive view at much deeper levels than before, allowing for the assessment of the extracellular matrix.

The composition of most lab-grown cartilage shows varying levels of vital components in the extracellular matrix, like collagen. Without the ability to see this variation, scientists cannot be certain that the tissues they transplant into the body will be safe and functional, making improvements to individual samples slow and iterative. By imaging such tissues without harming the cells, researchers will, for the first time, be able to have confidence that a transplant will work at half the cost. In the future, the team hopes to use this technology in operating theaters to image tumors in patients undergoing surgical removal, reducing the need for time-consuming study of tumor tissues while potentially saving time and lives.

“Tissue engineering has the potential to be life changing for many patients. Approximately, one in five people aged 45 suffer from osteoarthritis in the UK, and cartilage in the knee has no way of replacing itself. Transplantation with tissue engineered constructs could help solve that,” said Dr. Mads Bergholt, Reader in Biophotonics at King’s College London.

Related Links:
King’s College London


New
Gold Member
Automatic Hematology Analyzer
DH-800 Series
Portable Electronic Pipette
Mini 96
New
Automatic Chemiluminescence Immunoassay Analyzer
Shine i2000
New
ESR Analyzer
TEST1 2.0
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Left is the original cell image and right is same cell image zoomed in and rendered in the special imaging software (Photo courtesy of FIU)

Brain Inflammation Biomarker Detects Alzheimer’s Years Before Symptoms Appear

Alzheimer’s disease affects millions globally, but patients are often diagnosed only after memory loss and other symptoms appear, when brain damage is already extensive. Detecting the disease much earlier... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The VENTANA HER2 (4B5) test is now CE-IVDR approved (Photo courtesy of Roche)

Companion Diagnostic Test Identifies HER2-Ultralow Breast Cancer and Biliary Tract Cancer Patients

Breast cancer is the most common cancer in Europe, with more than 564,000 new cases and 145,000 deaths annually. Metastatic breast cancer is rising in younger populations and remains the leading cause... Read more

Technology

view channel
Image: Conceptual design of the CORAL capsule for microbial sampling in the small intestine (H. Mohammed et al., Device (2025). DOI: 10.1016/j.device.2025.100904)

Coral-Inspired Capsule Samples Hidden Bacteria from Small Intestine

The gut microbiome has been linked to conditions ranging from immune disorders to mental health, yet conventional stool tests often fail to capture bacterial populations in the small intestine.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.